Navigation Links
The Prevention of Heart Failure

ORLANDO, Fla., Sept. 22, 2013 /PRNewswire/ -- The 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session today entitled "The Prevention of Heart Failure." The session is being presented by HFSA and the American Heart Association.

Dr. Jay Cohn, Professor of Medicine at the University of Minnesota Medical School, will discuss the abnormalities of the arteries and the heart that result in cardiovascular disease morbidity and mortality. Dr. Cohn explains that these abnormalities can be detected years before people become sick.

"By detecting these abnormalities, we can identify individuals who will develop not only heart failure, but all cardiovascular diseases," said Dr. Cohn. "Our emphasis should be on detection and individualized treatment to prevent cardiovascular disease as a cause of sickness and death."

In addition to Dr. Cohn, the session will feature several other practitioners who will discuss screening for the risk of heart failure, the progression of heart failure and medical therapies to prevent heart failure.

For a complete list of annual meeting sessions or for details on attending the conference, call (617) 226-7193 or visit and click on Annual Scientific Meeting. There is also an app for the Annual Meeting available in the Apple Store by searching HFSA. There is no registration fee for accredited journalists. Interview areas will be available on-site in addition to a press room.  You may follow news from the meeting on Twitter @HFSA and #HFSA.

About Heart Failure
Heart failure is a progressive condition in which the heart muscle becomes weakened after it is injured, most commonly from heart attack or high blood pressure, and gradually loses its ability to pump enough blood to supply the body's needs. Many people are not aware they have heart failure because the symptoms are often mistaken for signs of getting older. Heart failure affects 4.6 to 4.8 million individuals in the United States. Demographic and clinical evidence strongly suggests that the prevalence of heart failure will increase throughout the next decade. Ten to 15 years ago heart failure was considered a "death sentence;" however, recent advances in treatment have shown that early diagnosis and proper care in early stages of the condition are key to slowing, stopping or in some cases reversing progression, improving quality of life, and extending life expectancy. For more information on heart failure, please visit

About the Heart Failure Society of America
The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. The HFSA provides a forum for all those interested in heart function, heart failure research and patient care. The Society also serves as a resource for governmental agencies (FDA, NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlight recent advances in the development of strategies to address the complex epidemiological, clinical and therapeutic issues of heart failure. Additional information on HFSA can be found at

SOURCE Heart Failure Society of America
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
2. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
3. New HIV prevention technology shows promise
4. Life Solutions Advocates Announces New Partnerships in Health Promotion and Disease Prevention Initiative
5. 2013 Cold & Flu Statistics According to the Center for Disease Control & Prevention
6. ITEC and Carometec Release New Sanitation Equipment, "The Mano Complete" For Foodborne Illness Prevention
7. Dr. Mark F. Rindge Launches Ground-Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
8. Transformation Dental Partners Launch Ground Breaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
9. Dr. David Slaughter Launches Groundbreaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
11. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
Breaking Biology Technology:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
Breaking Biology News(10 mins):